Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cancer drugs

Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cancer drugs

US Patent 11884708 · Granted Jan 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptidomimetics, method of synthesis and uses thereof2022
Peptidomimetics, method of synthesis and uses thereof2022
Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cance2021
Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cance2021
Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cance2021
Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cance2021
Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their n2018
Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their n2018
Conjugated molecules comprising a peptide derived from the CD4 receptor coupled 2018
Conjugated molecules comprising a peptide derived from the CD4 receptor coupled 2018
Glycoconjugates and their use as potential vaccines against infection by Shigell2016
Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their n2016